Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor—Case report and review of the literature-Reference-Cited by-同舟云学术

Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor—Case report and review of the literature

Published:2023-08-02 Issue:10 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Hughes Catherine¹,Harris Anora¹,Watkins Benjamin¹^ORCID,Qayed Muna¹,Parikh Suhag¹,Horwitz Edwin¹,Stenger Elizabeth¹,Williams Kirsten M.¹,Schoettler Michelle L.¹

Affiliation:

1. Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Emory University, Division of Pediatrics Emory University Atlanta Georgia USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30606

Reference13 articles.

1. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation - a systematic review and evidence-based guidance for clinical management

2. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

3. Keratinocyte growth factor ameliorates cyclophosphamide‐induced ulcerative hemorrhagic cystitis;Ulich TR;Cancer Res,1997

4. Treatment of Severe Hemorrhagic Cystitis after Allogeneic Stem Cell Transplantation with Palifermin, a Recombinant Human Keratinocyte Growth Factor

5. Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation